Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 19, 2026PharmaceuticalsOpen Access

Ferroptosis as a Therapeutic Vulnerability to Overcome Chemoresistance in Gastric Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

CCCarlo CalabreseTNTiziana Notarangelo

Discussion

Loading...

Member takes

Overview

This review discusses ferroptosis as a therapeutic target to combat chemoresistance in gastric cancer, suggesting new treatment strategies.

Key Points

  • The aim is to explore how ferroptosis contributes to chemoresistance in gastric cancer and how it can be targeted for therapeutic benefit.
  • Review of molecular mechanisms underlying ferroptosis and chemoresistance
  • Analysis of the dysregulation of the cystine-glutathione-GPX4 system
  • Discussion on strategies to exploit ferroptosis in cancer therapy.
  • Identified ferroptosis as a key vulnerability that gastric cancer cells evade to survive
  • Highlighted the role of iron metabolism and lipid remodeling in enabling chemoresistance
  • Proposed strategies for targeting ferroptosis to improve treatment outcomes.

Cite This Study

Calabrese et al. (2026) studied this question.

synapsesocial.com/papers/6a34e06865a5b0777af2f0e8https://doi.org/10.3390/ph19060949
View Full Paper
Ask AI
Bookmark
Share